ELMA is here!


We are very excited to introduce our first commercial product today! With our ELMA, methacylated elastin will soon be available for 3D printing for the first time! As an essential component of the extracellular matrix of all elastic tissues, our ELMA enables the production of artificial tissues by bioprinting!

matrihealth on tour! 


We are pleased to be present for the first time this year at the annual ESAO Symposium on Artificial Organs and Tissue Engineering. The symposium will take place in Wittenberg, Germany, from Feb. 15 to Feb. 18, 23. We are especially looking forward to present our ELMA, methacrylated elastin for biorprinting, for the first time. We are looking forward to exciting discussions and interesting insights into current research.


More information: https://www.esao.org/ 

      © ESAO

matriheal goes matrihealth 


On 04.10.2022 it was finally time, after almost 2 years of preparation, the notary appointment took place in Halle (Saale) and we could finally found the matrihealth GmbH! Many thanks to all who accompanied and supported us on the exciting way! We are looking forward to the coming time and to take the next steps together with you!

We are in! 


On November 23, 2022, the Fraunhofer Investment Forum 2022 will take place digitally and on-site in Munich. Together with other exciting spin-offs of the Fraunhofer Gesellschaft, we will have the opportunity to pitch to interested investors and hold exciting discussions. We are looking forward to it! 

Become a part of our story!


We are looking for investors and supporters with experience in the MedTech industry:


// Sales cooperation  
// Strategic partnerships
// Partners for approval and certification


Contact us! info@matrihealth.com

      © 2022

      © Fraunhofer IMWS / Michael Deutsch